| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
2014
|
50 |
S3 |
p. i-
1 p.
|
artikel
|
| 2 |
7LBA A 4 gene model can identify ER+HER2+ breast cancers unlikely to respond to neoadjuvant endocrine therapy
|
Turnbull, A.K.
|
|
2014
|
50 |
S3 |
p. S3-
1 p.
|
artikel
|
| 3 |
8LBA Assessing individual breast cancer risk within the UK National Health Service Breast Screening Programme: First prospective results from PROCAS
|
Evans, G.
|
|
2014
|
50 |
S3 |
p. S3-S4
2 p.
|
artikel
|
| 4 |
3LBA Axillary staging and treatment in breast cancer patients receiving neoadjuvant chemotherapy
|
van der Heiden-van der Loo, M.
|
|
2014
|
50 |
S3 |
p. S1-S2
2 p.
|
artikel
|
| 5 |
1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2
|
Piccart, M.
|
|
2014
|
50 |
S3 |
p. S1-
1 p.
|
artikel
|
| 6 |
5LBA Maastricht consensus on the definition of local event, second primary breast cancer, regional event, and distant event for classifying recurrence in breast cancer research
|
Moossdorff, M.
|
|
2014
|
50 |
S3 |
p. S2-S3
2 p.
|
artikel
|
| 7 |
4LBA RNA, protein or gene? ER, PgR and HER2 by local and central pathology review, and microarray readout (by TargetPrint) in the EORTC 10041/BIG 03-04 MINDACT trial
|
Cardoso, F.
|
|
2014
|
50 |
S3 |
p. S2-
1 p.
|
artikel
|
| 8 |
6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925
|
Struikmans, H.
|
|
2014
|
50 |
S3 |
p. S3-
1 p.
|
artikel
|
| 9 |
2LBA The first results of using intraoperative radiotherapy in treatment of women with breast cancer on early stages
|
Manikhas, A.
|
|
2014
|
50 |
S3 |
p. S1-
1 p.
|
artikel
|
Tijdschrift beschrijving